Journal of Molecular Pharmaceutics & Organic Process Research
黑料网
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Recommended Conferences
Vancouver, Canada
Zurich, Switzerland
Citations :
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Academic Keys
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Share This Page
2013: Volume 1, Issue 2
Intravaginal Rings as a Novel Platform for Mucosal Vaccination
Editorial: J Mol Pharm Org Process Res 2013, 1:e103
DOI: 10.4172/2329-9053.1000e103
Note on the Molecular Pharmaceutics and Organic Process
Editorial: J Mol Pharm Org Process Res 2013, 1: e104
DOI: 10.4172/2329-9053.1000e104
Novel Targets for Metal Compounds Inducing Carcinogenesis
Editorial: J Mol Pharm Org Process Res 2013, 1: e105
DOI: 10.4172/2329-9053.1000e105
Site-Specific Drug Delivery to the Gastrointestinal Tract
G Scott Weston and Kwame G Yeboah
Editorial: J Mol Pharm Org Process Res 2013, 1: e106
DOI: 10.4172/2329-9053.1000e106
Lipid-based Microtubes: A Promising Drug Carrier
Claudia Salerno and Carlos Bregni*
Short Communication: J Mol Pharm Org Process Res 2013, 1:103
DOI: 10.4172/2329-9053.1000103
Importance of Fluorine and Fluorocarbons in Medicinal Chemistry and Oncology
Farid Menaa, Bouzid Menaa and Olga N Sharts
Review Article: J Mol Pharm Org Process Res 2013, 1:104
DOI: 10.4172/2329-9053.1000104
Aptamer Functionalized Nanoparticles for Cancer Targeting
Carolina de Aguiar Ferreira and Andre Luis Branco de Barros
Editorial: J Mol Pharm Org Process Res 2013, 1:105
DOI: 10.4172/2329-9053.1000105
Role of In-silico modeling in Drug Development for Inhalation Treatment
Shengqian Wu, Sharareh Salar-Behzadi and Eleonore Fröhlich E
Short Communication: J Mol Pharm Org Process Res 2013, 1:106
DOI: 10.4172/2329-9053.1000106
